Review
Published on 20 Aug 2025
Advances of bispecific antibodies using/application in dermatology: a review
in Skin Allergy
Frontiers in Allergy
doi 10.3389/falgy.2025.1668931
- 1,688 views
128 articles related to "Bispecific Antibodies"
Articles
Original Research
Published on 06 Jan 2025
Effective cancer immunotherapy combining mRNA-encoded bispecific antibodies that induce polyclonal T cell engagement and PD-L1-dependent 4-1BB costimulation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1494206
- 7,021 views
- 1 citation
Review
Published on 29 May 2025
Bispecific antibody for lung cancer: mechanisms and clinical insights
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1572802
- 3,933 views
Review
Published on 23 Mar 2022
Bispecific Antibodies Progression in Malignant Melanoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2022.837889
- 5,146 views
- 7 citations
Review
Published on 10 Apr 2024
Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1394048
- 10,092 views
- 9 citations
Original Research
Published on 20 Apr 2023
Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1168444
- 7,072 views
- 4 citations
Mini Review
Published on 22 Jan 2025
Prodrug-based bispecific antibodies for cancer therapy: advances and future directions
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1523693
- 6,303 views
- 5 citations
Perspective
Published on 01 Sep 2017
VHH-Based Bispecific Antibodies Targeting Cytokine Production
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2017.01073
- 11,061 views
- 34 citations
Mini Review
Published on 11 Jan 2024
Bispecific antibodies in indolent B-cell lymphomas
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1295599
- 9,137 views
- 11 citations
Review
Published on 26 Jan 2017
Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2017.00038
- 62,032 views
- 101 citations
Original Research
Published on 03 Nov 2022
Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2022.1029214
- 6,334 views
- 7 citations
Original Research
Published on 08 Mar 2022
Computational Analysis of Cytokine Release Following Bispecific T-Cell Engager Therapy: Applications of a Logic-Based Model
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.818641
- 6,281 views
- 9 citations
Original Research
Published on 11 Jan 2022
Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of ‘Almost Natural’ Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2021.801368
- 7,095 views
- 23 citations
Original Research
Published on 10 Apr 2025
A mechanistic quantitative systems pharmacology model platform for translational efficacy evaluation and checkpoint combination design of bispecific immuno-modulatory antibodies
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1571844
- 2,221 views
Perspective
Published on 17 Dec 2014
Monitoring circulating gammadelta T cells in cancer patients to optimize gammadelta T cell-based immunotherapy
in T Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2014.00643
- 9,568 views
- 24 citations
Case Report
Published on 29 Nov 2024
Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1495233
- 3,474 views
- 3 citations